Søren Brøgger Christensen
Professor emeritus, Professor, emeritus
- Published
Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy
Denmeade, S. R., Mhaka, A. M., Rosen, D. M., Brennen, W. N., Dalrymple, S., Dach, I., Olesen, C., Gurel, B., DeMarzo, A. M., Wilding, G., Carducci, M. A., Dionne, C. A., Møller, J. V., Nissen, P., Christensen, Søren Brøgger & Isaacs, J. T., 27 Jun 2012, In: Science Translational Medicine. 4, 140, p. 140ra86Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
Denmeade, S. R., Jakobsen, C. M., Janssen, S., Khan, S. R., Garrett, E. S., Lilja, H., Christensen, Søren Brøgger & Isaacs, J. T., 2 Jul 2003, In: National Cancer Institute. Journal (Online). 95, 13, p. 990-1000 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Thapsigargin, origin, chemistry, structure-activity relationships and prodrug development.
Doan, T. Q. N. & Christensen, Søren Brøgger, Oct 2015, In: Current Pharmaceutical Design. 21, 38, p. 5505-5517 13 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Chemo- and regioselective functionalization of nortrilobolide: application for semi-synthesis of the natural product 2-acetoxytrilobolide
Doan, T. Q. N., Crestey, F., Olsen, C. E. & Christensen, Søren Brøgger, 2015, In: Journal of Natural Products. 78, 6, p. 1406-1414Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Novel thapsigargin analogues and methods of preparing them
Doan, T. Q. N., Christensen, Søren Brøgger & Crestey, F. L. J., 30 Dec 2015, Patent No. WO2015197860 A2, Priority date 27 Jun 2014, Priority No. DK20140070395 20140627Research output: Patent
- Published
Antiplasmodial Constituents of Cajanus cajan
Duker-Eshun, G., Jaroszewski, J. W., Asomaning, W. A., Oppong-Boachie, F. & Christensen, Søren Brøgger, 1 Feb 2004, In: Phytotherapy Research. 18, 2, p. 128-130 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Targeting Toxins toward Tumors
Franzyk, Henrik & Christensen, Søren Brøgger, 2021, In: Molecules. 26, 5, 23 p., 1292.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Noter til bioorganisk kemi M23-1
Franzyk, Henrik, Christensen, Søren Brøgger & Jaroszewski, J. W., 2007, København: Københavns Universitet, Det Farmaceutiske Fakultet, Institut for Medicinalkemi.Research output: Book/Report › Compendium/lecture notes › Education
- Published
Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum‐ATPase inhibitor thapsigargin
Gouy, H., Cefai, D., Christensen, Søren Brøgger, Debré, P. & Bismuth, G., Oct 1990, In: European Journal of Immunology. 20, 10, p. 2269-2275 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CDS-stimulated jurkat T cells: A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin
Gouy, H., Cefai, D., Christensen, Søren Brøgger, Debre, P. & Bismuth, G., 1 Aug 1991, In: Journal of Immunology. 147, 3, p. 757-766 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 1300951
Most downloads
-
1561
downloads
The antiparasitic compound Licochalcon A is a potent echinocytogenic agent that modifies erythrocyte membrane in the concentration region where the antiplasmodial activity is observed
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
339
downloads
Can phylogeny predict chemical diversity and potential medicinal activity of plants? A case study of Amaryllidaceae
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
306
downloads
Demethoxycurcumin is a potent inhibitor of P-type ATPases from diverse kingdoms of life
Research output: Contribution to journal › Journal article › Research › peer-review
Published